142273-84-5 Usage
General Description
3-Methoxymethylphenylboronic acid is a chemical compound with the molecular formula C8H11BO4. It is a boronic acid derivative that contains a boron atom bonded to a phenyl group and a methoxymethyl group. 3-Methoxymethylphenylboronic acid is used as a reagent in organic synthesis, particularly in the formation of carbon-carbon and carbon-oxygen bonds. It is an important intermediate for the preparation of pharmaceuticals, agrochemicals, and materials. Additionally, 3-Methoxymethylphenylboronic acid has been studied for its potential application in the treatment of cancer and other diseases. Its unique chemical structure and reactivity make it a valuable tool for organic chemists and researchers in a variety of fields.
Check Digit Verification of cas no
The CAS Registry Mumber 142273-84-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,2,2,7 and 3 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 142273-84:
(8*1)+(7*4)+(6*2)+(5*2)+(4*7)+(3*3)+(2*8)+(1*4)=115
115 % 10 = 5
So 142273-84-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H11BO3/c1-12-6-7-3-2-4-8(5-7)9(10)11/h2-5,10-11H,6H2,1H3
142273-84-5Relevant articles and documents
Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitors
-
, (2008/06/13)
Compounds of formula (I):or pharmaceutically or veterinarily acceptable salts thereof, or pharmaceutically or veterinarily acceptable solvates of either entity, wherein the broken line represents an optional bond; A is C or CH; B is CH2, O or absent; R1 and R2 are each independently selected from hydrogen, C1 to C6 alkyl optionally substituted with C1 to C4 alkoxy or phenyl, and C1 to C6 alkenyl; or, together with the carbon atom to which they are attached, form a C3 to C6 cycloalkyl group which optionally incorporates a heteroatom linkage selected from O, SO, SO2 and NR6 or which is optionally benzo-fused; R3 is hydrogen, halo, R7 or OR7; R4 is hydrogen, C1 to C4 alkyl, C1 to C4 alkoxy, trifluoromethyl or halo; R6 is hydrogen or C1 to C4 alkyl; R7 is an optionally substituted monocyclic or bicyclic ring system; m is 1 or 2; and n is 0, 1 or 2; with the proviso that B is not O when A is C; are MMP inhibitors useful in the treatment of, inter alia, tissue ulceration, wound repair and skin diseases.